Showing 3311-3320 of 20911 results for "".
- Immunotherapy Approach Shows Potential in Some People With Metastatic Solid Tumorshttps://reachmd.com/news/immunotherapy-approach-shows-potential-in-some-people-with-metastatic-solid-tumors/2467340/News ReleaseThursday, July 11, 2024 Immunotherapy approach shows potential in some people with metastatic solid tumors NIH researchers achieved tumor shrinkage in three of seven patients with colorectal cancers.Early findin
- Semaglutide Linked to Increased Risk of Severe Eye Condition NAION in New Studyhttps://reachmd.com/news/semaglutide-linked-to-increased-risk-of-severe-eye-condition-naion-in-new-study/2467302/A recent study published in the journal JAMA Ophthalmology evaluated associations between semaglutide and the risk of non-arteritic anterior ischemic o
- Researchers Identify Cause of Serious Brain Bleeding Condition in Premature Newbornshttps://reachmd.com/news/researchers-identify-cause-of-serious-brain-bleeding-condition-in-premature-newborns/2467294/A new study by investigators from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare, reveals insights that could lead to new treatments for a serious brain bleeding condition that’s common in newborns with very low birth weight. The findings are pu
- How Brain-Computer Interface Treatment for Strokes Is Helping Patients Recover Fasterhttps://reachmd.com/news/how-brain-computer-interface-treatment-for-strokes-is-helping-patients-recover-faster/2467297/Stroke Rehabilitation will be Shaped by the Development of Brain-Computer Interfaces Capturing both human and animal “thought” and using it for a range of purposes is not just science fiction anymore. Although brain-computer interface (BCI) has been in rese
- Fighting COVID-19 with a Cancer Drug: A New Approach to Preventing Irreversible Organ Damage in Infectious Diseaseshttps://reachmd.com/news/fighting-covid-19-with-a-cancer-drug-a-new-approach-to-preventing-irreversible-organ-damage-in-infectious-diseases/2467275/Unusually high numbers of macrophages (in brown) were detected in cross-sections of lungs from COVID-19 patients using immunohistochemical techniques. Blue counterstain detects nuclei of
- Doctor on How to Avoid 'World’s Most Infectious Disease’ as Cases Soar in UKhttps://reachmd.com/news/doctor-on-how-to-avoid-worlds-most-infectious-disease-as-cases-soar-in-uk/2467277/A doctor has issued crucial advice to Brits as cases of one of the world’s most infectious diseases continue to rise. Measles is seeing a resurgence not just in the UK but also on continental Europe. Measles is a viral illness which usually starts with cold-like symptoms, fo
- Researchers Identify a Novel Biomarker Linked to Renal Cancer Recurrencehttps://reachmd.com/news/researchers-identify-a-novel-biomarker-linked-to-renal-cancer-recurrence/2467278/Credit: Unsplash/CC0 Public Domain Researchers from the University of Michigan Health Rogel Cancer Center have discovered a biomarker that could help identify which renal cancer patients have a higher risk
- Declining Iron Levels in Women in Militaryhttps://reachmd.com/news/declining-iron-levels-in-women-in-military/2467286/After five months of basic military training, the proportion of female recruits with iron deficiency had more than doubled, from 25% to 55%. According to the researchers, this study calls for increased attention and action to improve iron levels.The study, published in the
- Researchers Find a Common Immune System Mechanism Between Pregnancy and Cancerhttps://reachmd.com/news/researchers-find-a-common-immune-system-mechanism-between-pregnancy-and-cancer/2467279/Credit: Cell (2024). DOI: 10.1016/j.cell.2024.06.012 To understand why some cancers successfully circumvent the immun
- Adding Sorafenib to TACE Improves PFS, OS in Recurrent HCChttps://reachmd.com/news/adding-sorafenib-to-tace-improves-pfs-os-in-recurrent-hcc/2467330/Adding sorafenib to transarterial chemoembolization (TACE) improves outcomes in patients with recurrent, intermediate-stage hepatocellular carcinoma (HCC), according to research published in JAMA Oncology. This phase 3 trial showed that patients who